Immediate Impact
2 by Nobel laureates 4 from Science/Nature 55 standout
Citing Papers
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
2023 Standout
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial
2023 Standout
Works of Thomas E. Davis being referenced
Toxicity and response criteria of the Eastern Cooperative Oncology Group
1982 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Thomas E. Davis | 1867 | 741 | 4412 | 3066 | 2247 | 106 | 11.2k | |
| Virginia A. Moyer | 2021 | 371 | 3230 | 3212 | 2159 | 105 | 11.2k | |
| John W. Epling | 2595 | 457 | 3489 | 2052 | 1891 | 117 | 12.5k | |
| Susan G. Fisher | 1585 | 465 | 2763 | 1819 | 2331 | 226 | 12.5k | |
| Linda S. Elting | 2173 | 1015 | 7206 | 6118 | 1838 | 194 | 15.1k | |
| Sy Ha | 1220 | 499 | 2532 | 2701 | 3970 | 324 | 13.8k | |
| John Horton | 1952 | 255 | 6782 | 5086 | 2737 | 104 | 16.3k | |
| Shahnaz Sultan | 2395 | 1925 | 2061 | 2000 | 4086 | 168 | 12.2k | |
| Gerry Oster | 1910 | 599 | 1860 | 3098 | 1818 | 235 | 11.9k | |
| Paolo Bruzzi | 1452 | 429 | 5024 | 1632 | 1681 | 323 | 14.0k | |
| Philipp Dahm | 1310 | 401 | 2177 | 4651 | 2998 | 344 | 14.8k |
All Works
Loading papers...